Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)primary central nervous system lymphomaActive, not recruitingPhase 22026-03-30NCT04947319

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Ono Pharmaceutical Co., Ltd.47

39 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Abramson Cancer Center University of PennsylvaniaPhiladelphiaUnited States1
Beth Israel Deaconess Medical CenterBostonUnited States462
City of Hope Comprehensive Breast Cancer CenterDuarteUnited States1
Cleveland ClinicClevelandUnited States21
Columbia University Irving Medical CenterNew YorkUnited States234
Dana-Farber Cancer Institute - Brigham & Women's HospitalBostonUnited States1
Duke University School of MedicineDurhamUnited States4
Georgetown University, Lombardi Comprehensive Cancer CenterWashington D.C.United States1
Hackensack University Medical Center - John Theurer CancerHackensackUnited States1
Henry Ford HospitalDetroitUnited States326
Hillman Cancer Center, University of PittsburghPittsburghUnited States1
Houston Methodist Research Institute (HMRI)HoustonUnited States1
Levine Cancer CenterCharlotteUnited States9
Lifespan Rhode Island HospitalProvidenceUnited States1
Massachusetts General HospitalBostonUnited States1015
Mayo Clinic- JacksonvilleJacksonvilleUnited States3
Mayo Clinic- PhoenixPhoenixUnited States3
MD Anderson Cancer CenterHoustonUnited States589
Memorial Sloan KetteringNew YorkUnited States2
Moffitt Cancer Center- MiamiPembroke PinesUnited States1
Orlando HealthOrlandoUnited States64
Penn State Hershey Cancer CenterHersheyUnited States1
Piedmont HealthcareAtlantaUnited States13
Providence Health Cancer CenterPortlandUnited States1
Roswell Park Comprehensive Cancer Center (RPCCC) (Roswell Park Cancer Institute (RPCI))BuffaloUnited States1